Monoclonal antibodies against LDL progressively oxidized by myeloperoxidase react with ApoB-100 protein moiety and human atherosclerotic lesions.
Moguilevsky
N
N
Applied Genetics, University of Brussels (ULB), IBMM, Gosselies, Belgium.
Zouaoui Boudjeltia
K
K
Babar
S
S
Delrée
P
P
Legssyer
I
I
Carpentier
Y
Y
Vanhaeverbeek
M
M
Ducobu
J
J
D000911:Antibodies, Monoclonal / Q000737:chemistry / Q000276:immunology*; D000918:Antibody Specificity / Q000276:immunology; D053299:Apolipoprotein B-100; D001055:Apolipoproteins B / Q000737:chemistry / Q000276:immunology*; D001161:Arteriosclerosis / Q000276:immunology*; D006801:Humans; D008077:Lipoproteins, LDL / Q000737:chemistry / Q000276:immunology*; D010084:Oxidation-Reduction; D009195:Peroxidase / Q000737:chemistry / Q000276:immunology*
D000911:Antibodies, Monoclonal; D053299:Apolipoprotein B-100; D001055:Apolipoproteins B; D008077:Lipoproteins, LDL; C099252:oxidized low density lipoprotein; D009195:Peroxidase